Detalles de la búsqueda
1.
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.
Br J Cancer
; 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745088
2.
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.
Lancet Oncol
; 24(3): 297-306, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36739879
3.
Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma.
BMC Cancer
; 23(1): 1061, 2023 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37924026
4.
Circulating DNA changes are predictive of disease progression after transarterial chemoembolization.
Int J Cancer
; 150(3): 532-541, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34622951
5.
Are patients living far from hospital at higher risk of late adjuvant chemotherapy for colon cancer?
Br J Clin Pharmacol
; 88(8): 3903-3910, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35293007
6.
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC).
Br J Cancer
; 125(5): 725-733, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34112948
7.
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
N Engl J Med
; 379(25): 2395-2406, 2018 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30575490
8.
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer.
Breast Cancer Res
; 22(1): 56, 2020 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32466779
9.
The Day after Tomorrow: How Should We Address Health System Organization to Treat Cancer Patients after the Peak of the COVID-19 Epidemic?
Oncology
; 98(12): 827-835, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683373
10.
Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients.
Support Care Cancer
; 27(2): 477-484, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978325
11.
Benefit of cetuximab addition to a platinum-fluorouracil-based chemotherapy according to KRAS-LCS6 variant in an unselected population of recurrent and/or metastatic head and neck cancers.
Eur Arch Otorhinolaryngol
; 276(2): 541-550, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30523411
12.
CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts.
HPB (Oxford)
; 21(5): 582-588, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30466797
13.
Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients.
Breast Cancer Res
; 20(1): 40, 2018 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29769099
14.
Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol.
BMC Cancer
; 18(1): 110, 2018 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29382311
15.
Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer.
Int J Cancer
; 140(7): 1653-1661, 2017 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28006840
16.
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours.
Br J Cancer
; 117(7): 1017-1025, 2017 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28772284
17.
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol.
BMC Cancer
; 17(1): 549, 2017 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28814281
18.
Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer.
Reprod Biomed Online
; 35(4): 468-474, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28652099
19.
Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.
Br J Clin Pharmacol
; 83(3): 623-631, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662818
20.
Morbidity-mortality conference for adverse events associated with totally implanted venous access for cancer chemotherapy.
Support Care Cancer
; 24(4): 1857-63, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26454864